JP2001501223A5 - - Google Patents

Download PDF

Info

Publication number
JP2001501223A5
JP2001501223A5 JP1998516587A JP51658798A JP2001501223A5 JP 2001501223 A5 JP2001501223 A5 JP 2001501223A5 JP 1998516587 A JP1998516587 A JP 1998516587A JP 51658798 A JP51658798 A JP 51658798A JP 2001501223 A5 JP2001501223 A5 JP 2001501223A5
Authority
JP
Japan
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP1998516587A
Other languages
English (en)
Japanese (ja)
Other versions
JP4714313B2 (ja
JP2001501223A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US1997/016599 external-priority patent/WO1998014168A2/en
Publication of JP2001501223A publication Critical patent/JP2001501223A/ja
Publication of JP2001501223A5 publication Critical patent/JP2001501223A5/ja
Application granted granted Critical
Publication of JP4714313B2 publication Critical patent/JP4714313B2/ja
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

JP51658798A 1996-09-30 1997-09-16 剤形および薬剤の投与法 Expired - Lifetime JP4714313B2 (ja)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US2872696P 1996-09-30 1996-09-30
US60/028,726 1996-09-30
US3051496P 1996-11-12 1996-11-12
US60/030,514 1996-11-12
US4412197P 1997-04-22 1997-04-22
US60/044,121 1997-04-22
PCT/US1997/016599 WO1998014168A2 (en) 1996-09-30 1997-09-16 Dosage form providing a sustained and ascending drug release

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2010110166A Division JP5697893B2 (ja) 1996-09-30 2010-05-12 剤形および薬剤の投与法

Publications (3)

Publication Number Publication Date
JP2001501223A JP2001501223A (ja) 2001-01-30
JP2001501223A5 true JP2001501223A5 (enExample) 2005-05-12
JP4714313B2 JP4714313B2 (ja) 2011-06-29

Family

ID=27363329

Family Applications (3)

Application Number Title Priority Date Filing Date
JP51658798A Expired - Lifetime JP4714313B2 (ja) 1996-09-30 1997-09-16 剤形および薬剤の投与法
JP2010110166A Expired - Lifetime JP5697893B2 (ja) 1996-09-30 2010-05-12 剤形および薬剤の投与法
JP2013213661A Ceased JP2014028854A (ja) 1996-09-30 2013-10-11 剤形および薬剤の投与法

Family Applications After (2)

Application Number Title Priority Date Filing Date
JP2010110166A Expired - Lifetime JP5697893B2 (ja) 1996-09-30 2010-05-12 剤形および薬剤の投与法
JP2013213661A Ceased JP2014028854A (ja) 1996-09-30 2013-10-11 剤形および薬剤の投与法

Country Status (11)

Country Link
EP (1) EP0932388B1 (enExample)
JP (3) JP4714313B2 (enExample)
CN (1) CN1231603A (enExample)
AT (1) ATE321529T1 (enExample)
AU (1) AU4801497A (enExample)
CA (1) CA2264852C (enExample)
DE (1) DE69735581T2 (enExample)
DK (1) DK0932388T5 (enExample)
ES (1) ES2262174T3 (enExample)
PT (1) PT932388E (enExample)
WO (1) WO1998014168A2 (enExample)

Families Citing this family (47)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6440457B1 (en) 1993-05-27 2002-08-27 Alza Corporation Method of administering antidepressant dosage form
US5837284A (en) 1995-12-04 1998-11-17 Mehta; Atul M. Delivery of multiple doses of medications
PT932388E (pt) * 1996-09-30 2006-07-31 Alza Corp Forma de dosagem e metodo para administracao de farmacos
US6919373B1 (en) 1996-11-12 2005-07-19 Alza Corporation Methods and devices for providing prolonged drug therapy
US6962997B1 (en) 1997-05-22 2005-11-08 Celgene Corporation Process and intermediates for resolving piperidyl acetamide steroisomers
KR100827254B1 (ko) 1998-06-03 2008-05-07 알자 코포레이션 연장된 약물 치료를 제공하기 위한 방법 및 장치
CN1209098C (zh) * 1998-06-03 2005-07-06 阿尔扎有限公司 提供药物长效治疗的方法和装置
AU2012232984B2 (en) * 1998-06-03 2015-10-29 Alza Corporation Methods and devices for providing prolonged drug therapy
AU2004200938B2 (en) * 1998-06-03 2006-09-14 Alza Corporation Methods and devices for providing prolonged drug therapy
US6322819B1 (en) 1998-10-21 2001-11-27 Shire Laboratories, Inc. Oral pulsed dose drug delivery system
IL142896A0 (en) 1998-11-02 2002-04-21 Elan Corp Plc Multiparticulate modified release composition
US7083808B2 (en) 1998-12-17 2006-08-01 Euro-Celtique S.A. Controlled/modified release oral methylphenidate formulations
US6673367B1 (en) * 1998-12-17 2004-01-06 Euro-Celtique, S.A. Controlled/modified release oral methylphenidate formulations
US6419960B1 (en) 1998-12-17 2002-07-16 Euro-Celtique S.A. Controlled release formulations having rapid onset and rapid decline of effective plasma drug concentrations
EP2295043A1 (en) 1999-10-29 2011-03-16 Euro-Celtique S.A. Controlled release hydrocodone formulations
US10179130B2 (en) 1999-10-29 2019-01-15 Purdue Pharma L.P. Controlled release hydrocodone formulations
AU2002227383B2 (en) 2000-10-30 2004-07-08 Euro-Celtique S.A. Controlled release hydrocodone formulations
WO2003037244A2 (en) * 2001-10-29 2003-05-08 Therics, Inc. System for manufacturing controlled release dosage forms, such as a zero-order release profile dosage form manufactured by three-dimensional printing
JP2010229140A (ja) * 2002-02-22 2010-10-14 Shire Llc 活性物質送達系及び活性物質を保護し投与する方法
US20050232995A1 (en) 2002-07-29 2005-10-20 Yam Nyomi V Methods and dosage forms for controlled delivery of paliperidone and risperidone
US7988993B2 (en) 2002-12-09 2011-08-02 Andrx Pharmaceuticals, Inc. Oral controlled release dosage form
JP2008509144A (ja) * 2004-08-04 2008-03-27 アルザ・コーポレーシヨン 上昇するゼロ次放出パターンを示す持続薬剤放出組成物、そのような組成物を製造する方法
DK1791530T3 (da) 2004-08-23 2008-10-27 Pejo Iserlohn Heilmittel Und D Farmaceutisk komposition indeholdende et psykostimulerende middel
US8541026B2 (en) 2004-09-24 2013-09-24 Abbvie Inc. Sustained release formulations of opioid and nonopioid analgesics
ATE536867T1 (de) 2006-03-16 2011-12-15 Tris Pharma Inc Modifizierte freisetzungsformulierungen mit arznei-ion-austausch-harzkomplexen
US8846100B2 (en) 2006-05-12 2014-09-30 Shire Llc Controlled dose drug delivery system
EP1920768A1 (en) * 2006-11-10 2008-05-14 Abbott GmbH & Co. KG Solid dosage form with a film containing an active substance, as well as its method of production
JP2011511782A (ja) 2008-02-12 2011-04-14 アボット・ラボラトリーズ 長期放出性ヒドロコドンアセトアミノフェンならびにその関連方法および用途
US9498447B2 (en) 2011-03-23 2016-11-22 Ironshore Pharmaceuticals & Development, Inc. Compositions for treatment of attention deficit hyperactivity disorder
US8927010B2 (en) 2011-03-23 2015-01-06 Ironshore Pharmaceuticals & Development, Inc. Compositions for treatment of attention deficit hyperactivity disorder
WO2012129551A1 (en) 2011-03-23 2012-09-27 Ironshore Pharmaceuticals & Development, Inc. Methods and compositions for treatment of attention deficit disorder
US10292937B2 (en) 2011-03-23 2019-05-21 Ironshore Pharmaceuticals & Development, Inc. Methods of treatment of attention deficit hyperactivity disorder
US8916588B2 (en) 2011-03-23 2014-12-23 Ironshore Pharmaceuticals & Development, Inc. Methods for treatment of attention deficit hyperactivity disorder
US9283214B2 (en) 2011-03-23 2016-03-15 Ironshore Pharmaceuticals & Development, Inc. Compositions for treatment of attention deficit hyperactivity disorder
US9119809B2 (en) 2011-03-23 2015-09-01 Ironshore Pharmaceuticals & Development, Inc. Compositions for treatment of attention deficit hyperactivity disorder
US11241391B2 (en) 2011-03-23 2022-02-08 Ironshore Pharmaceuticals & Development, Inc. Compositions for treatment of attention deficit hyperactivity disorder
US9603809B2 (en) 2011-03-23 2017-03-28 Ironshore Pharmaceuticals & Development, Inc. Methods of treatment of attention deficit hyperactivity disorder
US10905652B2 (en) 2011-03-23 2021-02-02 Ironshore Pharmaceuticals & Development, Inc. Compositions for treatment of attention deficit hyperactivity disorder
CA2880456A1 (en) 2012-08-15 2014-02-20 Tris Pharma, Inc. Methylphenidate extended release chewable tablet
BR112015020261A2 (pt) 2013-03-29 2017-07-18 Wockhardt Ltd composições farmacêuticas de dexmetilfenidato ou sais do mesmo de liberação modificada
DE102013014417A1 (de) 2013-08-29 2015-03-05 Klinipharm Gmbh Schwammkollagen umfassende Zubereitungen mit definiertem in vivo-Freisetzungsprofil vor allem im Colon, deren Herstellung und Verwendung
WO2015188092A1 (en) * 2014-06-06 2015-12-10 Rhodes Pharmaceuticals, L.P. Methods for treating attention deficit hyperactivity disorder with methylphenidate
CA3018328A1 (en) 2014-10-31 2016-04-30 Purdue Pharma Methods and compositions particularly for treatment of attention deficit disorder
US11590228B1 (en) 2015-09-08 2023-02-28 Tris Pharma, Inc Extended release amphetamine compositions
US11590081B1 (en) 2017-09-24 2023-02-28 Tris Pharma, Inc Extended release amphetamine tablets
US12458592B1 (en) 2017-09-24 2025-11-04 Tris Pharma, Inc. Extended release amphetamine tablets
US10722473B2 (en) 2018-11-19 2020-07-28 Purdue Pharma L.P. Methods and compositions particularly for treatment of attention deficit disorder

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2738303A (en) * 1952-07-18 1956-03-13 Smith Kline French Lab Sympathomimetic preparation
US3400197A (en) * 1965-01-26 1968-09-03 Robins Co Inc A H Compressible sustained release pharmaceutical tablet lipid-colloidal silica gel matrix fragment granules
US3625214A (en) * 1970-05-18 1971-12-07 Alza Corp Drug-delivery device
DE2336218C3 (de) * 1973-07-17 1985-11-14 Byk Gulden Lomberg Chemische Fabrik Gmbh, 7750 Konstanz Orale Arzneiform
US4304591A (en) * 1978-01-25 1981-12-08 Ciba-Geigy Corporation Water-insoluble hydrophilic copolymers used as carriers for medicaments and pesticides
EP0094123A3 (en) * 1982-05-06 1984-07-25 THE PROCTER & GAMBLE COMPANY Therapeutic granules
EP0212747B1 (en) * 1985-08-16 1991-04-10 The Procter & Gamble Company Drug particles having constant release and immediate release
LU86077A1 (fr) * 1985-09-18 1987-04-02 Pharlyse Sa Nouvelles formes galeniques du verapamil,leur fabrication et medicaments contenant ces nouvelles formes galeniques
DE3822095A1 (de) * 1988-06-30 1990-01-04 Klinge Co Chem Pharm Fab Neue arzneimittelformulierung sowie verfahren zu deren herstellung
SE509029C2 (sv) * 1988-08-16 1998-11-30 Ss Pharmaceutical Co Långtidsverkande diklofenak-natriumpreparat
US4927639A (en) * 1989-02-02 1990-05-22 Warner-Lambert Company Modified release gemfibrozil composition
FI93924C (fi) * 1991-09-17 1995-06-26 Martti Lauri Antero Marvola Menetelmä säädellysti lääkeainetta vapauttavan valmisteen valmistamiseksi
EP0664118B1 (en) * 1991-10-04 1999-08-25 Yoshitomi Pharmaceutical Industries, Ltd. Sustained-release tablet
PT957899E (pt) * 1996-08-16 2003-07-31 Alza Corp Forma de dosagem para proporcionar um medicamento numa dose crescente
PT932388E (pt) * 1996-09-30 2006-07-31 Alza Corp Forma de dosagem e metodo para administracao de farmacos

Similar Documents

Publication Publication Date Title
JP2001509146A5 (enExample)
JP2001509286A5 (enExample)
JP2001513659A5 (enExample)
JP2001504338A5 (enExample)
JP2000515319A5 (enExample)
JP2001502556A5 (enExample)
JP2001507081A5 (enExample)
JP2001500276A5 (enExample)
JP2001502005A5 (enExample)
JP2000508322A5 (enExample)
JP2000511106A5 (enExample)
JP2000510510A5 (enExample)
JP2001507676A5 (enExample)
JP2000516851A5 (enExample)
JP2000506123A5 (enExample)
JP2000513663A5 (enExample)
JP2000511697A5 (enExample)
JP2000503912A5 (enExample)
JP2000511443A5 (enExample)
JP2000514963A5 (enExample)
JP2000514709A5 (enExample)
JP2000512341A5 (enExample)
JP2001513118A5 (enExample)
JP2001503413A5 (enExample)
JP2000508673A5 (enExample)